跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML - HSA Drug Approval Details
Approvals
/
HSA
/
OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML
Approved
STANDARD
OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
96f7ee3ea71bf471
Company
Unknown
Type
Standard
Approval Details
Approval Id
96f7ee3ea71bf471
Drug Name
OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML
Active Ingredients
Ocrelizumab
300 mg/10 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
96f7ee3ea71bf471
Type
Standard
Back to HSA Approvals
